Northern Trust’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-13,763
| Closed | -$102K | – | 4512 |
|
|
2026
Q1 | $102K | Hold |
13,763
| – | – | ﹤0.01% | 4101 |
|
|
2025
Q4 | $86.6K | Sell |
13,763
-177
| -1% | -$1.03K | ﹤0.01% | 4161 |
|
|
2025
Q3 | $54.4K | Hold |
13,940
| – | – | ﹤0.01% | 4273 |
|
|
2025
Q2 | $63.8K | Hold |
13,940
| – | – | ﹤0.01% | 4198 |
|
|
2025
Q1 | $68K | Hold |
13,940
| – | – | ﹤0.01% | 4186 |
|
|
2024
Q4 | $93.7K | Buy |
13,940
+4,901
| +54% | +$36.5K | ﹤0.01% | 4167 |
|
|
2024
Q3 | $69.9K | Sell |
9,039
-35,939
| -80% | -$217K | ﹤0.01% | 4138 |
|
|
2024
Q2 | $270K | Sell |
44,978
-6,558
| -13% | -$49.8K | ﹤0.01% | 3749 |
|
|
2024
Q1 | $465K | Sell |
51,536
-2,811
| -5% | -$25.6K | ﹤0.01% | 3586 |
|
|
2023
Q4 | $515K | Sell |
54,347
-2,632
| -5% | -$23.1K | ﹤0.01% | 3529 |
|
|
2023
Q3 | $678K | Buy |
56,979
+1,161
| +2% | +$20.6K | ﹤0.01% | 3427 |
|
|
2023
Q2 | $1.37M | Sell |
55,818
-39,626
| -42% | -$1.03M | ﹤0.01% | 3225 |
|
|
2023
Q1 | $2.99M | Sell |
95,444
-2,567
| -3% | -$149K | ﹤0.01% | 2751 |
|
|
2022
Q4 | $6.9M | Buy |
98,011
+358
| +0.4% | +$26.5K | ﹤0.01% | 2259 |
|
|
2022
Q3 | $8.41M | Buy |
97,653
+5,001
| +5% | +$486K | ﹤0.01% | 2106 |
|
|
2022
Q2 | $7.66M | Buy |
92,652
+48,909
| +112% | +$4.31M | ﹤0.01% | 2237 |
|
|
2022
Q1 | $7.27M | Buy |
43,743
+2,086
| +5% | +$299K | ﹤0.01% | 2352 |
|
|
2021
Q4 | $6.96M | Sell |
41,657
-648
| -2% | -$73.2K | ﹤0.01% | 2494 |
|
|
2021
Q3 | $3.65M | Sell |
42,305
-2,031
| -5% | -$134K | ﹤0.01% | 2934 |
|
|
2021
Q2 | $2.41M | Buy |
44,336
+12,645
| +40% | +$718K | ﹤0.01% | 3272 |
|
|
2021
Q1 | $1.89M | Sell |
31,691
-2,233
| -7% | -$131K | ﹤0.01% | 3274 |
|
|
2020
Q4 | $1.77M | Sell |
33,924
-1,214
| -3% | -$67.5K | ﹤0.01% | 3253 |
|
|
2020
Q3 | $1.7M | Buy |
35,138
+4,302
| +14% | +$206K | ﹤0.01% | 3133 |
|
|
2020
Q2 | $1.6M | Sell |
30,836
-2,523
| -8% | -$127K | ﹤0.01% | 3159 |
|
|
2020
Q1 | $1.46M | Buy |
33,359
+19,054
| +133% | +$775K | ﹤0.01% | 3030 |
|
|
2019
Q4 | $574K | Sell |
14,305
-936
| -6% | -$28.8K | ﹤0.01% | 3525 |
|
|
2019
Q3 | $500K | Buy |
15,241
+1,952
| +15% | +$94.2K | ﹤0.01% | 3537 |
|
|
2019
Q2 | $1.02M | Buy |
13,289
+588
| +5% | +$91.4K | ﹤0.01% | 3350 |
|
|
2019
Q1 | $2.25M | Buy |
12,701
+7,002
| +123% | +$1.38M | ﹤0.01% | 3007 |
|
|
2018
Q4 | $1.34M | Buy |
5,699
+458
| +9% | +$112K | ﹤0.01% | 3256 |
|
|
2018
Q3 | $1.12M | Buy |
+5,241
| New | +$915K | ﹤0.01% | 3442 |
|
Northern Trust's KZR Position: Q2 2026 in Review
Northern Trust sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 13,763 shares — an estimated $102K sold.
Northern Trust first reported a position in KZR in Q3 2018 and held it in 31 quarters. The position peaked at $8.41M in Q3 2022. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.
- Northern Trust reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
- Northern Trust sold 13,763 Kezar Life Sciences shares in Q2 2026, an estimated $102K.
- Northern Trust first reported a position in Kezar Life Sciences in Q3 2018 and held it in 31 quarters.
- Northern Trust's Kezar Life Sciences position peaked at $8.41M in Q3 2022.
- 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.
Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.